Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs

Overview of attention for article published in Biomarker Research, May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#15 of 312)
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 13 X users

patent: 3 patents

Citations

dimensions_citation: 204 Dimensions

Readers on

mendeley: 215 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 15 X posts from 13 X users, with an upper bound of 39,837 followers.

@AnneMillsMD HR mutations part of the story, functional outcome of HR defects gives a different list of PARPi sensitive tumors https://t.co/LLuxpW0nSB

13 Oct 2017

Reply Repost Favourite

MT @TCGAupdates: Pan-cancer analysis suggests novel indications for existing cancer drugs #TCGA Biomarker Res (OA) http://t.co/Vt0cR7sgSk

24 Jun 2015

Reply Repost Favourite

Pan-cancer analysis of genomic scar signatures suggests novel indications for existing cancer drugs #openaccess #TCGA http://t.co/9DDU9RbidS

23 Jun 2015

Reply Repost Favourite

Pan-cancer analysis of genomic scar signatures suggests novel indications for existing cancer drugs #openaccess #TCGA http://t.co/9DDU9RbidS

23 Jun 2015

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.